The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cg Oncology Inc shares valued at $200,450 were sold by POST LEONARD E on Sep 30 ’25. At $40.09 per share, POST LEONARD E sold 5,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Mulay James sold 12,755 shares, netting a total of over 499,868 in proceeds. Following the sale of shares at $39.19 each, the insider now holds 0 shares.
Before that, LEONARD E POST had added 5,000 shares to its account. In a trade valued at $195,400, the Director bought Cg Oncology Inc shares for $39.08 each.
As published in their initiating research note from Piper Sandler on August 19, 2025, Cg Oncology Inc [CGON] has been an Overweight and the price target has been revised to $55. As of May 02, 2025, JP Morgan has initiated its “an Overweight” rating for CGON. Earlier on April 16, 2025, Scotiabank initiated its rating. Their recommendation was “a Sector perform” for CGON stock.
Analyzing CGON Stock Performance
On last trading session, Cg Oncology Inc [NASDAQ: CGON] rose 1.00% to $39.85. The stock’s lowest price that day was $38.36, but it reached a high of $40.36 in the same session. During the last five days, there has been a surge of approximately 9.25%. Over the course of the year, Cg Oncology Inc shares have jumped approximately 5.63%. Shares of the company reached a 52-week high of $40.65 on 10/01/25 and a 52-week low of $14.80 on 04/09/25.
Support And Resistance Levels for Cg Oncology Inc (CGON)
According to the 24-hour chart, there is a support level at 38.69, which, if violated, would cause prices to drop to 37.53. In the upper region, resistance lies at 40.69. The next price resistance is at 41.53. RSI (Relative Strength Index) is 73.29 on the 14-day chart, showing overbought technical sentiment.
Is Cg Oncology Inc subject to short interest?
Stocks of Cg Oncology Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.68 million shares to 11.01 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 10.33 million shares. A jump of 6.19% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.27 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.27.
Which companies own the most shares of Cg Oncology Inc (CGON)?
In terms of Cg Oncology Inc share price expectations, FactSet research, analysts set an average price target of 67 in the next 12 months, up nearly 69.79% from the previous closing price of $39.46. Analysts anticipate Cg Oncology Inc stock to reach 79 by 2025, with the lowest price target being 55. In spite of this, 4 analysts ranked Cg Oncology Inc stock as Buy at the end of 2025.
